MedTrace Logo

Lutronic Infini and LaseMD Systems in Combination Treatment

NCT03409965 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2018-08-23

No results posted yet for this study

Summary

This is a prospective, multi-site, non-randomized study evaluating the safety and effectiveness of the Infini and LaseMD Systems for combination treatment in wrinkles, texture, and pigmentation of the face and/or neck.

Conditions

  • Face and Neck Wrinkles, Texture, Pigmentation

Interventions

DEVICE

Lutronic Infini System

A microneedle radiofrequency device

DEVICE

Lutronic LaseMD System

A fractional thulium laser device

Sponsors & Collaborators

  • LUTRONIC Corporation

    lead INDUSTRY

Principal Investigators

  • Kari Larson, MBA · Sponsor GmbH

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-08
Primary Completion
2018-08-21
Completion
2018-08-21
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03409965 on ClinicalTrials.gov